Business Wire

Accumetrics’ VerifyNow System Receives Health Canada License for Clinical Use

SAN DIEGO--(BUSINESS WIRE)--Accumetrics, Inc., developer of the VerifyNow ® System, the first rapid and easy-to-use system for measuring platelet reactivity to multiple antiplatelet agents, announced ...
TCTMD

Accumetrics Obtains CE Mark for Therapeutic Window Claim on the VerifyNow P2Y12 Test

Accumetrics, Inc., developer of the market-leading VerifyNow® System, announced an expansion in the intended use for the CE marked VerifyNow P2Y12 Test. Physicians can now use the test results to ...
Medgadget

VerifyNow™ Aspirin System

Aspirin is a powerful and important medication in management of various cardiovascular diseases. Simply put, aspirin shuts down the platelets, a clot-producing cells, and mainly through this action ...
TCTMD

2011 ACCF/AHA Guidelines Incorporate New Recommendation for Platelet Reactivity Testing

SAN DIEGO, Accumetrics, Inc., developer of the VerifyNow® System, the first rapid and easy-to-use point-of-care system for measuring platelet reactivity to multiple antiplatelet agents, announced ...
Medindia

Accumetrics, Inc. Announces Endotech SPA as Exclusive Distributor for the VerifyNow System in Italy

SAN DIEGO, Sept. 15 Accumetrics, Inc. announces today it has signed a new exclusive agreement with Endotech SPA for distribution of its VerifyNow(R) System in Italy. With the addition of Endotech to ...
elEconomista

ADAPT-DES Finds Stent Thrombosis Rate Approximately Four Times Higherin Patients With High Platelet Reactivity, Measured by VerifyNow System

Accumetrics, Inc., developer of the VerifyNow ® System, the first rapid and easy-to-use point-of-care system for measuring platelet reactivity to multiple antiplatelet agents, today announced that ...
Medindia

VerifyNow(R) System Highlighted in POPular Study Comparing Platelet Reactivity Tests

SAN DIEGO, Nov. 19 Accumetrics, Inc., developer of the VerifyNow System, the first point-of-care method for measuring platelet reactivity, announces that its market-leading VerifyNow P2Y12 Test was ...
GEN

Accumetrics Allies with Portola to Develop Clinical Test for Platelet Reactivity

VerifyNow System, a point-of-care diagnostic, will be designed for use in clinical studies. Accumetrics and Portola Pharmaceuticals will together develop and supply Accumetrics’ VerifyNow System and ...
Engadget

VerifyNow Aspirin System doles out proper doses

San Diego-based Accumetrics has developed a system for home use called VerifyNow that can accurately predict the necessary dose of Aspirin for a particular patient. Apparently, many people taking ...
PR Newswire

New CE Marked Prognostic Claim for the VerifyNow P2Y12 Test

SAN DIEGO, May 17, 2011 /PRNewswire/ -- Accumetrics, Inc., developer of the VerifyNow(R) System, the first rapid and easy-to-use point-of-care system for measuring platelet reactivity to multiple ...
elEconomista

Accumetrics Obtains CE Mark for Therapeutic Window Claim on theVerifyNow P2Y12 Test

Accumetrics, Inc., developer of the market-leading VerifyNow ® System, announced an expansion in the intended use for the CE marked VerifyNow P2Y12 Test. Physicians can now use the test results to ...